Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2021 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2021 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats

  • Authors:
    • Zhimin Li
    • Xing Cao
    • Ligen Xiao
    • Ruijiao Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China, Department of Cardiothoracic Surgery, Nanchong Central Hospital, Nanchong, Sichuan 637000, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 1045
    |
    Published online on: July 22, 2021
       https://doi.org/10.3892/etm.2021.10478
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cerebral ischemia is among the leading causes of death and long‑term disability worldwide. The aim of the present study was to investigate the effects of aloperine (ALO) on cerebral ischemia/reperfusion (I/R) injury in rats and elucidate the possible underlying mechanisms. Therefore, a rat model of reversible middle cerebral artery occlusion (MCAO) was established to induce cerebral I/R injury. Following pretreatment with different doses of ALO, the histopathological changes in the brain tissue were evaluated by hematoxylin and eosin staining. The degree of cerebral infarction was determined using by 2,3,5‑triphenyltetrazolium chloride staining. Additionally, the levels of oxidative stress‑ and inflammation‑related factors were measured using commercially available kits. Cell apoptosis was assessed by TUNEL staining, while the expression levels of apoptosis‑ and PI3K/AKT signaling pathway‑related proteins were determined by western blot analysis. The results demonstrated that ALO alleviated histopathological injury in the brain tissue and the area of cerebral infarction in a dose‑dependent manner. Furthermore, significantly reduced levels of reactive oxygen species and malondialdehyde were observed in the ALO‑treated rats post‑MCAO/reperfusion, accompanied by increased levels of superoxide dismutase, catalase and glutathione. Consistently, treatment with ALO notably decreased the concentration of inflammatory factors, including TNF‑α, IL‑1β and IL‑6, in a dose‑dependent manner. In addition, ALO attenuated neuronal cell apoptosis, downregulated the expression of Bax and upregulated that of Bcl‑2. I/R markedly reduced the expression levels of phosphorylated (p‑)PI3K and p‑AKT, which were dose‑dependently restored by ALO intervention. Collectively, the aforementioned findings indicated that ALO could improve cerebral I/R injury and alleviate oxidative stress, inflammation and cell apoptosis via activating the PI3K/AKT signaling pathway, thus supporting the therapeutic potential of ALO against cerebral I/R injury in ischemic stroke.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Wang Z, Zhou W, Dong H, Ma X and He Z: Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusioninduced neuroinflammation via activation of AMPK. Mol Med Rep. 18:3957–3964. 2018.PubMed/NCBI View Article : Google Scholar

2 

GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392:1736–1788. 2018.PubMed/NCBI View Article : Google Scholar

3 

Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, Niizuma K, Katsu M, Okami N, Yoshioka H, et al: Reperfusion and neurovascular dysfunction in stroke: From basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol. 41:172–179. 2010.PubMed/NCBI View Article : Google Scholar

4 

Zhao Y and Xu J: Sanggenon C Ameliorates cerebral Ischemia-Reperfusion injury by inhibiting inflammation and oxidative stress through regulating RhoA-ROCK signaling. Inflammation. 43:1476–1487. 2020.PubMed/NCBI View Article : Google Scholar

5 

Esenwa CC and Elkind MS: Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol. 12:594–604. 2016.PubMed/NCBI View Article : Google Scholar

6 

Yin F, Zhou H, Fang Y, Li C, He Y, Yu L, Wan H and Yang J: Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway. J Ethnopharmacol. 248(112319)2020.PubMed/NCBI View Article : Google Scholar

7 

Brosius AD, Ziller JW and Zhang Q: Relative and absolute configuration of aloperine. Acta Crystallogr C. 53 (Pt 10):1510–1512. 1997.PubMed/NCBI View Article : Google Scholar

8 

Zhao P, Zhou R, Zhu XY, Hao YJ, Li N, Wang J, Niu Y, Sun T, Li YX and Yu JQ: Matrine attenuates focal cerebral ischemic injury by improving antioxidant activity and inhibiting apoptosis in mice. Int J Mol Med. 36:633–644. 2015.PubMed/NCBI View Article : Google Scholar

9 

Zhao J, Zhang G, Li M, Luo Q, Leng Y and Liu X: Neuro-protective effects of aloperine in an Alzheimer's disease cellular model. Biomed Pharmacother. 108:137–143. 2018.PubMed/NCBI View Article : Google Scholar

10 

Hu S, Zhang Y, Zhang M, Guo Y, Yang P, Zhang S, Simsekyilmaz S, Xu JF, Li J, Xiang X, et al: Aloperine protects mice against Ischemia-Reperfusion (IR)-induced renal injury by regulating PI3K/AKT/mTOR signaling and AP-1 activity. Mol Med. 21:912–923. 2016.PubMed/NCBI View Article : Google Scholar

11 

Ma NT, Zhou R, Chang RY, Hao YJ, Ma L, Jin SJ, Du J, Zheng J, Zhao CJ, Niu Y, et al: Protective effects of aloperine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion. J Nat Med. 69:575–583. 2015.PubMed/NCBI View Article : Google Scholar

12 

Song S, Chen Y, Han F, Dong M, Xiang X, Sui J, Li Y, Yang H and Liu J: Aloperine activates the Nrf2-ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model. Exp Ther Med. 15:3847–3855. 2018.PubMed/NCBI View Article : Google Scholar

13 

Wang M, Chen Z, Yang L and Ding L: Sappanone A protects against inflammation, oxidative stress and apoptosis in cerebral Ischemia-Reperfusion injury by alleviating endoplasmic reticulum stress. Inflammation. 44:934–945. 2021.PubMed/NCBI View Article : Google Scholar

14 

Wu F, Yao W, Yang J, Zhang M, Xu Y, Hao Y, Yan L, Niu Y, Sun T, Yu J and Zhou R: Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats. Biomed Pharmacother. 95:1161–1168. 2017.PubMed/NCBI View Article : Google Scholar

15 

Song G, Huang Y, Xiong M, Yang Z, Liu Q, Shen J, Zhao P and Yang X: Aloperine relieves Type 2 diabetes mellitus via enhancing GLUT4 expression and translocation. Front Pharmacol. 11(561956)2021.PubMed/NCBI View Article : Google Scholar

16 

Bork K, Wurm F, Haller H, Strauss C, Scheller C, Gnanapragassam VS and Horstkorte R: Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth. Molecules. 20:1003–1013. 2015.PubMed/NCBI View Article : Google Scholar

17 

Moran JM and Pedrera-Zamorano JD: Comments on ‘Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: A randomized controlled trial’. BMC Complement Altern Med. 17(119)2017.PubMed/NCBI View Article : Google Scholar

18 

Chen X, Yao Z, Peng X, Wu L, Wu H, Ou Y and Lai J: Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF-κB signaling pathway. Mol Med Rep. 22:5135–5144. 2020.PubMed/NCBI View Article : Google Scholar

19 

Sanz JM, Chiozzi P, Colaianna M, Zotti M, Ferrari D, Trabace L, Zuliani G and Di Virgilio F: Nimodipine inhibits IL-1beta release stimulated by amyloid beta from microglia. Br J Pharmacol. 167:1702–1711. 2012.PubMed/NCBI View Article : Google Scholar

20 

Han K, Rong W, Wang Q, Qu J, Li Q, Bi K and Liu R: Time-dependent metabolomics study of cerebral ischemia-reperfusion and its treatment: Focus on the combination of traditional Chinese medicine and Western medicine. Anal Bioanal Chem. 412:7195–7209. 2020.PubMed/NCBI View Article : Google Scholar

21 

Zou S, Zhang M, Feng L, Zhou Y, Li L and Ban L: Protective effects of notoginsenoside R1 on cerebral ischemia-reperfusion injury in rats. Exp Ther Med. 14:6012–6016. 2017.PubMed/NCBI View Article : Google Scholar

22 

Trotman-Lucas M, Kelly ME, Janus J and Gibson CL: Middle cerebral artery occlusion allowing reperfusion via common carotid artery repair in mice. J Vis Exp. 2019.PubMed/NCBI View Article : Google Scholar

23 

Shi Y, Peng XH, Li X, Luo GP and Wu MF: Neuroprotective role of dexmedetomidine pretreatment in cerebral ischemia injury via ADRA2A-mediated phosphorylation of ERK1/2 in adult rats. Exp Ther Med. 16:5201–5209. 2018.PubMed/NCBI View Article : Google Scholar

24 

Hu Q, Chen C, Yan J, Yang X, Shi X, Zhao J, Lei J, Yang L, Wang K, Chen L, et al: Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp Neurol. 216:35–46. 2009.PubMed/NCBI View Article : Google Scholar

25 

Hao MQ, Xie LJ, Leng W and Xue RW: Trim47 is a critical regulator of cerebral ischemia-reperfusion injury through regulating apoptosis and inflammation. Biochem Biophys Res Commun. 515:651–657. 2019.PubMed/NCBI View Article : Google Scholar

26 

Park SJ, Nam KW, Lee HJ, Cho EY, Koo U and Mar W: Neuroprotective effects of an alkaloid-free ethyl acetate extract from the root of Sophora flavescens Ait. against focal cerebral ischemia in rats. Phytomedicine. 16:1042–1051. 2009.PubMed/NCBI View Article : Google Scholar

27 

Zhao P, Zhou R, Li HN, Yao WX, Qiao HQ, Wang SJ, Niu Y, Sun T, Li YX and Yu JQ: Oxymatrine attenuated hypoxic-ischemic brain damage in neonatal rats via improving antioxidant enzyme activities and inhibiting cell death. Neurochem Int. 89:17–27. 2015.PubMed/NCBI View Article : Google Scholar

28 

Peters O, Back T, Lindauer U, Busch C, Megow D, Dreier J and Dirnagl U: Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 18:196–205. 1998.PubMed/NCBI View Article : Google Scholar

29 

Yang Z, Weian C, Susu H and Hanmin W: Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms. Eur J Pharmacol. 771:145–151. 2016.PubMed/NCBI View Article : Google Scholar

30 

Wang Q, Sun AY, Simonyi A, Jensen MD, Shelat PB, Rottinghaus GE, MacDonald RS, Miller DK, Lubahn DE, Weisman GA and Sun GY: Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res. 82:138–148. 2005.PubMed/NCBI View Article : Google Scholar

31 

Wang TF, Lei Z, Li YX, Wang YS, Wang J, Wang SJ, Hao YJ, Zhou R, Jin SJ, Du J, et al: Oxysophoridine protects against focal cerebral ischemic injury by inhibiting oxidative stress and apoptosis in mice. Neurochem Res. 38:2408–2417. 2013.PubMed/NCBI View Article : Google Scholar

32 

Zhang B, Zhong Q and Chen X, Wu X, Sha R, Song G, Zhang C and Chen X: Neuroprotective effects of celastrol on transient global cerebral ischemia rats via regulating HMGB1/NF-ĸB signaling pathway. Front Neurosci. 14(847)2020.PubMed/NCBI View Article : Google Scholar

33 

Ahmad A, Khan MM, Raza SS, Javed H, Ashafaq M and Islam F, Safhi MM and Islam F: Ocimum sanctum attenuates oxidative damage and neurological deficits following focal cerebral ischemia/reperfusion injury in rats. Neurol Sci. 33:1239–1247. 2012.PubMed/NCBI View Article : Google Scholar

34 

Wei W, Lan XB, Liu N, Yang JM, Du J, Ma L, Zhang WJ, Niu JG, Sun T and Yu JQ: Echinacoside alleviates hypoxic-ischemic brain injury in neonatal rat by enhancing antioxidant capacity and inhibiting apoptosis. Neurochem Res. 44:1582–1592. 2019.PubMed/NCBI View Article : Google Scholar

35 

Wu F, Hao Y, Yang J, Yao W, Xu Y, Yan L, Niu Y, Sun T, Yu J and Zhou R: Protective effects of aloperine on monocrotaline-induced pulmonary hypertension in rats. Biomed Pharmacother. 89:632–641. 2017.PubMed/NCBI View Article : Google Scholar

36 

Zhang J, Zhou H, Chen J, Lv X and Liu H: Aloperine protects human retinal pigment epithelial cells against hydrogen peroxide-induced oxidative stress and apoptosis through activation of Nrf2/HO-1 pathway. J Recept Signal Transduct Res: Nov 30, 2020 (Epub ahead of print).

37 

Han B, Lu Y, Zhao H, Wang Y, Li L and Wang T: Electroacupuncture modulated the inflammatory reaction in MCAO rats via inhibiting the TLR4/NF-κB signaling pathway in microglia. Int J Clin Exp Pathol. 8:11199–11205. 2015.PubMed/NCBI

38 

Hou SZ, Li Y, Zhu XL, Wang ZY, Wang X and Xu Y: Ameliorative effects of diammonium glycyrrhizinate on inflammation in focal cerebral ischemic-reperfusion injury. Brain Res. 1447:20–27. 2012.PubMed/NCBI View Article : Google Scholar

39 

Shichita T, Sakaguchi R, Suzuki M and Yoshimura A: Post-ischemic inflammation in the brain. Front Immunol. 3(132)2012.PubMed/NCBI View Article : Google Scholar

40 

Liu Q and Zhang Y: PRDX1 enhances cerebral ischemia-reperfusion injury through activation of TLR4-regulated inflammation and apoptosis. Biochem Biophys Res Commun. 519:453–461. 2019.PubMed/NCBI View Article : Google Scholar

41 

Kao TK, Ou YC, Liao SL, Chen WY, Wang CC, Chen SY, Chiang AN and Chen CJ: Opioids modulate post-ischemic progression in a rat model of stroke. Neurochem Int. 52:1256–1265. 2008.PubMed/NCBI View Article : Google Scholar

42 

Zhao J, Li L and Fang G: Salvianolic acid A attenuates cerebral ischemia/reperfusion injury induced rat brain damage, inflammation and apoptosis by regulating miR-499a/DDK1. Am J Transl Res. 12:3288–3301. 2020.PubMed/NCBI

43 

Chang Z, Zhang P, Zhang M, Jun F, Hu Z, Yang J, Wu Y and Zhou R: Aloperine suppresses human pulmonary vascular smooth muscle cell proliferation via inhibiting inflammatory response. Chin J Physiol. 62:157–165. 2019.PubMed/NCBI View Article : Google Scholar

44 

Mao Q, Guo F, Liang X, Wu Y and Lu Y: Aloperine activates the PI3K/Akt Pathway and protects against coronary microembolisation-induced myocardial injury in rats. Pharmacology. 104:90–97. 2019.PubMed/NCBI View Article : Google Scholar

45 

Cantley LC: The phosphoinositide 3-kinase pathway. Science. 296:1655–1657. 2002.PubMed/NCBI View Article : Google Scholar

46 

Feng C, Wan H, Zhang Y, Yu L, Shao C, He Y, Wan H and Jin W: Neuroprotective effect of Danhong injection on cerebral Ischemia-Reperfusion injury in rats by activation of the PI3K-Akt pathway. Front Pharmacol. 11(298)2020.PubMed/NCBI View Article : Google Scholar

47 

Yu Y, Jia XJ, Zong QF, Zhang GJ, Ye HW, Hu J, Gao Q and Guan SD: Remote ischemic postconditioning protects the heart by upregulating ALDH2 expression levels through the PI3K/Akt signaling pathway. Mol Med Rep. 10:536–542. 2014.PubMed/NCBI View Article : Google Scholar

48 

Wang Z, Han Y, Tian S, Bao J, Wang Y and Jiao J: Lupeol alleviates cerebral Ischemia-Reperfusion injury in correlation with modulation of PI3K/Akt pathway. Neuropsychiatr Dis Treat. 16:1381–1390. 2020.PubMed/NCBI View Article : Google Scholar

49 

Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, Gala R and Simon RP: In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: Ischemic postconditioning. J Cereb Blood Flow Metab. 28:232–241. 2008.PubMed/NCBI View Article : Google Scholar

50 

Fu X, Sun F, Wang F, Zhang J, Zheng B, Zhong J, Yue T, Zheng X, Xu JF and Wang CY: Aloperine protects mice against DSS-induced colitis by PP2A-mediated PI3K/Akt/mTOR signaling suppression. Mediators Inflamm. 2017(5706152)2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Z, Cao X, Xiao L and Zhou R: Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats. Exp Ther Med 22: 1045, 2021.
APA
Li, Z., Cao, X., Xiao, L., & Zhou, R. (2021). Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats. Experimental and Therapeutic Medicine, 22, 1045. https://doi.org/10.3892/etm.2021.10478
MLA
Li, Z., Cao, X., Xiao, L., Zhou, R."Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats". Experimental and Therapeutic Medicine 22.4 (2021): 1045.
Chicago
Li, Z., Cao, X., Xiao, L., Zhou, R."Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats". Experimental and Therapeutic Medicine 22, no. 4 (2021): 1045. https://doi.org/10.3892/etm.2021.10478
Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Cao X, Xiao L and Zhou R: Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats. Exp Ther Med 22: 1045, 2021.
APA
Li, Z., Cao, X., Xiao, L., & Zhou, R. (2021). Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats. Experimental and Therapeutic Medicine, 22, 1045. https://doi.org/10.3892/etm.2021.10478
MLA
Li, Z., Cao, X., Xiao, L., Zhou, R."Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats". Experimental and Therapeutic Medicine 22.4 (2021): 1045.
Chicago
Li, Z., Cao, X., Xiao, L., Zhou, R."Aloperine protects against cerebral ischemia/reperfusion injury via activating the PI3K/AKT signaling pathway in rats". Experimental and Therapeutic Medicine 22, no. 4 (2021): 1045. https://doi.org/10.3892/etm.2021.10478
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team